Optimizing Medication Management in ACS: The Role of the Pharmacist Across the Continuum of Care Sponsored by AstraZeneca

Sunday, October 19, 2014, 11:30 am - 1:30 pm
Austin Convention Center
Location: Ballroom E, Level 4
Continuing Education Credits: 1.5 (0.15 Contact Hours)
ACPE #: 0245-0000-14-022-L01-P

Evidence-based guidelines for acute coronary syndromes (ACS) emphasize the need for treatment with antiplatelet therapies during hospitalization and continued long-term to prevent recurrent events. Adherence to medications following ACS is generally poor, with the largest decline occurring in the transition period from hospital to home resulting in significantly higher readmissions and mortality. Pharmacists are essential healthcare professionals in identifying and correcting medication non-adherence and pharmacist involvement during the transition of care process has been shown to improve patient outcomes. This multi-component educational initiative aims to educate pharmacists in a variety of healthcare settings to optimize medication management for ACS patients throughout each transition of care.

Pharmacist Learning Objectives:

  1. Appraise the latest clinical guideline recommendations for the treatment and secondary prevention of ACS and discuss optimal duration of dual antiplatelet therapy (DAPT).

  2. Analyze available P2Y12 inhibitors examining differences in side effects, drug-drug interactions, and pharmacogenomics/kinetics in order to tailor antiplatelet selection and counseling to optimize adherence.

  3. Identify potential barriers to medication adherence and create patient specific plans to improve long-term adherence to antiplatelet therapy.

  4. Formulate strategies to improve the transition of care process for ACS patients in a variety of clinical settings while highlighting best practices.

Speakers: Toby C. Trujillo, PharmD, FCCP, FAHA, BCPS (AQ Cardiology), activity chair, associate professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, clinical specialist - Anticoagulation/Cardiology, University of Colorado Hospital, Aurora, Colorado; Danielle Blais, PharmD, BCPS, Specialty Practice Pharmacist, Cardiology, The Ohio State University, Columbus, Ohio; Joe Moose, PharmD, Moose Compounding Pharmacy, Concord, North Carolina

Activity Type: Application-based
Audience: Pharmacists